In 2025, Pfizer conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Waste Generated | 110,700a | 114,100a | 116,500a | |
Total Waste Recovered | 23,800a | 32,200a | 29,600a | |
Total Hazardous Waste Generated | 77,800a | 79,600a | 80,300a | |
Non-Hazardous Waste Disposed | 14,000a | 14,900a | 17,000a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Pfizer generated a total of 110,700metric tonnes of waste.a
Of this amount, 21.5% of Pfizer's total waste generated was recovered through methods such as recycling, reuse, or composting, while 78.5% was disposed of through landfilling, incineration, or combustion.a
In 2025, Pfizer reported a total waste generation of 110,700 metric tonnes, of which 21.5% was recovered through recycling, reuse, or composting.This low recovery rate highlights limited waste diversion and suggests that Pfizer may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.a
Since 2023, Pfizer's total waste generation decreased by 4.98%, including a further 2.98% drop in 2025, highlighting a consistent and deliberate reduction in waste production over time.a
Over the same period, Pfizer's waste recovery rate declined by 15.38%, with a further 23.82% drop in 2025, underscoring a weakening in waste diversion performance and a potential drift away from circular waste strategies.a
Overall, while Pfizer has successfully reduced its total waste generation, its waste recovery efforts have also declined. This pattern could suggest a shift in strategy away from circular treatment methods or a lag in recovery infrastructure development.
In 2025, Pfizer generated a total of 110,700 metric tonnes of waste.a
Of this amount, 70.28% of Pfizer's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.29.72% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2023, Pfizer's total waste generation decreased by 4.98%, with an additional 2.98% decline in 2025, suggesting a consistent and deliberate effort to minimize waste generation at the source.a
Over the same period, the share of hazardous waste increased by 1.96%, while holding steady in 2025, pointing to potential stagnation in efforts to reduce harmful waste types after a period of worsening performance.a
Overall, Pfizer's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a
In 2025, Pfizer reported that 77,800 metric tonnes of its total waste output were classified as hazardous. This represents 70.28% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.Only 6.3% of hazardous waste was recovered, meaning the vast majority was treated through disposal methods such as landfilling or incineration. This raises concerns about the environmental and health risks associated with Pfizer’s current hazardous waste practices.a